Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1321 AL 1335

Comorbidity Between Restless Legs Syndrome and Migraine: Observations From a Tertiary Care Center in Northern India

Singh B, Paul BS, Singh S, Jain A, Kaushal H, Paul G.

Neurol India. 2026 Jul 1;74(4):606-610. doi: 10.4103/neurol-india.Neurol-India-D-25-00971. Epub 2026 Jul 21.

Molecular Signatures of Ferroptosis in Sleep Disorders: A Comparative Analysis of GPX4, ACSL4, and TfR1

Biçer EÖ, İsmailoğulları S, Hamurcu Z, Güler A, Eşel G, Önal MG, Çıkın S, Zararsız G.

Mol Neurobiol. 2026 Jul 25;63(1):790. doi: 10.1007/s12035-026-06075-5.

Current and Emerging Therapies for Pediatric Sleep Disorders: A Narrative Review

Estrada Chaverri L, DelRosso LM, Ceballos Fuentes FA.

Neurol Ther. 2026 Oct;15(5):2321-2339. doi: 10.1007/s40120-026-01002-1. Epub 2026 Jul 29.

The evolving treatment landscape of restless legs syndrome

Mogavero MP, Lanza G, Tondo P, Bruni O, Ferri R.

Ther Adv Neurol Disord. 2026 Jul 28;19:17562864261469017. doi: 10.1177/17562864261469017. eCollection 2026.

Restless Legs Syndrome and Periodic Limb Movements

Gorantla S.

Continuum (Minneap Minn). 2026 Aug;32(4):1117-1141. doi: 10.1212/cont.0000000000001741. Epub 2026 Aug 3.

Restless legs syndrome or diabetic peripheral neuropathy: diagnostic dilemmas and clinical insights from a case report

Zhang Y, Nan X, Chu L.

Front Endocrinol (Lausanne). 2026 Aug 4;17:1899929. doi: 10.3389/fendo.2026.1899929. eCollection 2026.

Sleep disturbance in CKD: patient‑prioritized outcomes, management, and perceptions - a multicenter mixed-methods study in Australia

Chu G, Viecelli AK, Chacko B, Fernandez R, Russo S, Abdul Latheef V, Lazarus B, Matricciani L, Foster C, Blackamore C, Le Leu R, Jesudason S.

Ren Fail. 2026 Dec;48(1):2714693. doi: 10.1080/0886022X.2026.2714693. Epub 2026 Aug 24.

Stiff Person Syndrome in the Hospice Patient: A Case Report and Discussion

Svendsen M, Layton BP, Etzioni S, Edwin M.

J Palliat Med. 2026 Aug;29(8):1175-1177. doi: 10.1177/10966218251387432. Epub 2025 Oct 13.

[Stiff-person syndrome; the diagnostic challenges of a treatable condition]

Bos JW, de Vries JM, van Doormaal PTC.

Ned Tijdschr Geneeskd. 2026 Jun 2;170:D8853.

Triple islet autoantibody-positive type 1 diabetes in Japanese stiff-person syndrome despite a protective HLA haplotype

Suenaga M, Ogiso K, Takeuchi N, Akahoshi H, Nishio Y, Morino K.

JCEM Case Rep. 2026 Jun 9;4(7):luag154. doi: 10.1210/jcemcr/luag154. eCollection 2026 Jul.

Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study

Qiu Y, Huang Z, Ma T, Lan L, Ma G, Nie K, Zhang Y, Wang L, Zhao J.

Ther Adv Neurol Disord. 2026 Jun 9;19:17562864261456519. doi: 10.1177/17562864261456519. eCollection 2026.

Movement disorders with autoimmune neuromuscular origin: an overview of Isaacs' syndrome, stiff person syndrome, immune-mediated rippling muscle disease

Arimura K, Rosales RL, Arimura Y, Yu GLT.

J Neural Transm (Vienna). 2026 Jun 29. doi: 10.1007/s00702-026-03220-1. Online ahead of print.

Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis

Hu Y, Wen M, Wen L, Cheng R, Shen Y, Aboseif A, Shang P.

J Neurol. 2026 Jul 2;273(8):442. doi: 10.1007/s00415-026-13981-0.

Sequential efgartigimod and ofatumumab for stiff-person syndrome: a case report illustrating a pathophysiology-informed strategy and literature review

Yang C, Zhou J, Jiang H.

Front Immunol. 2026 Jun 26;17:1811565. doi: 10.3389/fimmu.2026.1811565. eCollection 2026.

Case Report: Efgartigimod: a beacon of hope for overlapping stiff-person syndrome and myasthenia gravis following thymoma

Nie J, Yin W.

Front Immunol. 2026 Jul 20;17:1825974. doi: 10.3389/fimmu.2026.1825974. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias